# Viking Therapeutics, Inc.: Form 8-K, filed Sep 28, 2026

- Company: [Viking Therapeutics, Inc.](/companies/vktx.md) (CIK 1607678)
- Form: 8-K
- Filed: 2026-09-28
- Accepted by EDGAR: Sep 28, 2026, 17:27 ET
- Period: 2026-09-23
- Accession: 0001193125-26-405580
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1607678/000119312526405580/vktx-20260923.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1607678/000119312526405580/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1607678/000119312526405580/vktx-20260923.htm

Filed Sep 28, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-405580. Last ingested by Listed: Nov 5, 2026, 14:02 ET. No prices; not investment advice.